InsiderTradr

Smruthi Organics Limited (SMRUTHIORG.BO)

BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic

₹135.80 (+1.00%) as of

Key statistics

Market cap
1.55B
P/E (TTM)
20.83
EPS (TTM)
6.52
Dividend yield
1.12%
52-week range
95.00 – 175.30
Beta
0.08
Revenue (TTM)
1.12B
Profit margin
6.58%
Volume
1.06k

About Smruthi Organics Limited

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company operates through Bulk Drugs and Drugs Intermediates (API), and Formulation segments. The company provides API for cardiovascular, such as amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine. In addition, the company is developing empagliflozin for anti-diabetics; and apixaban and rivaroxaban for anti-platelets. It also exports its products. The company was incorporated in 1989 and is headquartered in Solapur, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Solapur, India
Employees
261

smruthiorganics.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks